Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial
about
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Zoledronic acid for prevention ...... zed controlled phase III trial
@en
Zoledronic acid for prevention ...... ed controlled phase III trial.
@nl
type
label
Zoledronic acid for prevention ...... zed controlled phase III trial
@en
Zoledronic acid for prevention ...... ed controlled phase III trial.
@nl
prefLabel
Zoledronic acid for prevention ...... zed controlled phase III trial
@en
Zoledronic acid for prevention ...... ed controlled phase III trial.
@nl
P2093
P2860
P1476
Zoledronic acid for prevention ...... zed controlled phase III trial
@en
P2093
Barbara Pro
Camillo Jimenez
Felipe Samaniego
Fredrick B Hagemeister
Jason R Westin
Jatin Shah
Jorge Romaguera
Larry W Kwak
Luis E Fayad
P2860
P304
P356
10.1016/J.CLML.2012.11.002
P407
P50
P577
2012-12-29T00:00:00Z